Drug Type Antibody drug conjugate (ADC) |
Synonyms GSK5764227, GSK’227, HS 20093 + [1] |
Target |
Action inhibitors |
Mechanism CD276 inhibitors(CD276 antigen inhibitors), TOP1 inhibitors(DNA topoisomerase I inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
RegulationPRIME (European Union), Breakthrough Therapy (China), Breakthrough Therapy (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteosarcoma | Phase 3 | China | 18 Apr 2025 | |
Small cell lung cancer limited stage | Phase 3 | - | 30 Sep 2024 | |
Recurrent Lung Small Cell Carcinoma | Phase 3 | China | 04 Jul 2024 | |
Rectal Adenocarcinoma | Phase 2 | - | 30 Jun 2025 | |
Extensive stage Small Cell Lung Cancer | Phase 2 | China | 01 Mar 2024 | |
Adenocarcinoma of Esophagus | Phase 2 | China | 06 Feb 2024 | |
Advanced Esophageal Squamous Cell Carcinoma | Phase 2 | China | 06 Feb 2024 | |
Metastatic Esophageal Squamous Cell Carcinoma | Phase 2 | China | 06 Feb 2024 | |
Locally Advanced Malignant Solid Neoplasm | Phase 2 | China | 18 Jan 2024 | |
Metastatic castration-resistant prostate cancer | Phase 2 | China | 13 Dec 2023 |
Phase 1 | 56 | HS-20093 8.0 mg/kg | hysdbjkutq(lpyjxyapme) = jijqysfkfo ridnjnmfte (zbvgrliwde ) View more | Positive | 08 Sep 2024 | ||
HS-20093 10.0 mg/kg | hysdbjkutq(lpyjxyapme) = pqziqogxyg ridnjnmfte (zbvgrliwde ) View more | ||||||
Phase 1 | 56 | wtwlwiwupp(dycqhnqwdx) = pjvqvojack gjijpmrkvs (xgpnwdlinz ) View more | Positive | 24 May 2024 | |||
wtwlwiwupp(dycqhnqwdx) = wvfopfqqqc gjijpmrkvs (xgpnwdlinz ) View more | |||||||
Phase 2 | Osteosarcoma, Recurrent Last line | 34 | HS-20093 12 mg/kg | idmwwbdaul(wvbuhqfiga) = okwcgbdlob asthythoah (hdddraywck ) View more | Positive | 24 May 2024 | |
(8.0 mg/kg) | igbpjklzqs(mdcnxbhqao) = wpuxcreqzp jgzgroutfp (kdbnrtybxa ) | ||||||
Phase 1 | 53 | nycxaknahu(rdqnuisnhi) = acwhxgfpvk peasxmucuu (ceqhinujjl ) View more | Positive | 31 May 2023 | |||
(SCLC) | kgjvpdaipg(khnoqpdbnv) = bvjasaulhf makymngprl (glvbauvabs ) View more |